Associate Professor of Medicine, Johns Hopkins University School of Medicine
Infectious Disease
Dr. Gregory M. Lucas, MD
|
|
Give Review
Gregory M. Lucas, MD practices Infectious Disease. He attended Duke University School of Medicine. Duke University School of Medicine is a one of the best medicals schools. Duke University School of Medicine is ranked 8/29 in Research/PrimaryCare. Dr. Gregory M. Lucas is also published. He has 76 publications published. The lastest publication: "Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals.'
Publications
- Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals.
- Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine-Naloxone: HIV Prevention Trials Network 058.
- High HIV burden among people who inject drugs in 15 Indian cities.
- End-Stage Renal Disease Among HIV-Infected Adults in North America.
- Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
- Executive Summary: Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association ...
- Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious D...
- Patient-centered care for people living with multimorbidity.
- Drug Interactions and Antiretroviral Drug Monitoring.
- Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals.
- Impact of generic antiretroviral therapy (ART) and free ART programs on time to initiation of ART at a tertiary HIV care center in Chennai, India.
- Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.
- Comparison of Risk Factors and Outcomes in HIV Immune Complex Kidney Disease and HIV-Associated Nephropathy.
- HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.
- HIV Viremia and T-Cell Activation Differentially Affect the Performance of Glomerular Filtration Rate Equations Based on Creatinine and Cystatin C.
- Risk Factors for Vitamin D Deficiency among HIV-Infected and Uninfected Injection Drug Users.
- HIV notes from the 39th Annual Meeting of the IDSA.
- Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.
- Antiretroviral toxicities take center stage at the 9th CROI (Conference on Retroviruses and Opportunistic Infections).
- Treatment of antiretroviral-experienced patients and immune-based therapy.
- Selected topics from the 9th Conference on Retroviruses and Opportunistic Infections.
- HIV notes from the 40th annual meeting of the Infectious Diseases Society of America.
- Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?
- Taking HAART to heart: antiretroviral toxicities.
- Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study.
- Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study.
- Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). The treatment of experienced patients and resistance mechanisms.
- Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study.
- Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing.
- Buprenorphine in primary HIV care clinics: a big pill to swallow.
- Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven.
- An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002.
- Adherence to antiretroviral therapy: an update of current concepts.
- Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.
- 3rd IAS conference: new drugs and treatment of experienced patients.
- Treatment of experienced patients and antiretroviral resistance issues from the 12th CROI.
- Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003.
- Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent compariso...
- Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort.
- Initial strategies for integrating buprenorphine into HIV care settings in the United States.
- Buprenorphine use: the international experience.
- Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.
- Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
- Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
- Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). New data on treatment-experienced patients and drug resistance.
- Cocaine use and hypertensive renal changes in HIV-infected individuals.
- End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004.
- Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and design.
- Observations on a cohort of HIV-infected patients undergoing native renal biopsy.
- Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland.
- Poor validity of urine dipstick as a screening tool for proteinuria in HIV-positive patients.
- A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort.
- Kidney biopsy in HIV: beyond HIV-associated nephropathy.
- Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races.
- Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.
- HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management.
- Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status.
- Antiretroviral nephrotoxicities.
- Nonstructured treatment interruptions among injection drug users in Baltimore, MD.
- Mortality among injection drug users in Chennai, India (2005-2008).
- Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infection.
- Kidney function and the risk of cardiovascular events in HIV-1-infected patients.
- Characteristics of patients with HIV and biopsy-proven acute interstitial nephritis.
- Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial.
- Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda.
- Role of HIV-1 DNA levels as clinical marker of HIV-1-associated nephropathies.
- HIV and proteinuria in an injection drug user population.
- Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.
- Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care.
- HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multi...
- Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs.
- The Impact of Hepatitis C Coinfection on Kidney Disease Related to Human Immunodeficiency Virus (HIV): A Biopsy Study.
- Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users.
- The Clinical Characteristics and Pathological Patterns of Postinfectious Glomerulonephritis in HIV-Infected Patients.
- Directly Administered Antiretroviral Therapy for HIV-Infected Individuals in Opioid Treatment Programs: Results from a Randomized Clinical Trial.
Schools
Duke University
Johns Hopkins University School Med
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Johns Hopkins University -
Duke University School of Medicine
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1093751810 | |
| NPPES Provider LastName | LUCAS | |
| NPPES Provider FirstName | GREGORY | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 1370.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 65.0 | |
| Percent Opioid Claims | 4.74 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093751810 |
| Last Name Of The Provider | LUCAS |
| First Name Of The Provider | GREGORY |
| View All |
Similar Doctors
|
|
Dr. Deborah F. Weber, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick A. Ryscavage, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luciana L. Borio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naomi O'Grady, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ethel D. Weld, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Petros Karakousis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Surbhi Leekha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kirsten E. Lyke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas C. Macharia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dimitra Mitsani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrea L. Cox, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lesia K. Dropulic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chloe L. Thio, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|